These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17301763)

  • 21. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 22. A survey of South-North health biotech collaboration.
    Melon CC; Ray M; Chakkalackal S; Li M; Cooper JE; Chadder J; Ke W; Li L; Madkour MA; Aly S; Adly N; Chaturvedi S; Konde V; Daar AS; Singer PA; Thorsteinsdóttir H
    Nat Biotechnol; 2009 Mar; 27(3):229-32. PubMed ID: 19270665
    [No Abstract]   [Full Text] [Related]  

  • 23. Start up and succeed.
    Kaplan K
    Nature; 2009 Nov; 462(7272):530-1. PubMed ID: 20066758
    [No Abstract]   [Full Text] [Related]  

  • 24. Innovative startups 2013.
    Huggett B
    Nat Biotechnol; 2014 Feb; 32(2):127. PubMed ID: 24509750
    [No Abstract]   [Full Text] [Related]  

  • 25. The nuts and bolts of startups.
    Kiplinger J; Last K
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE29-31. PubMed ID: 12089583
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioengineering and translational research.
    Kim Y
    IEEE Eng Med Biol Mag; 2005; 24(2):5. PubMed ID: 15825837
    [No Abstract]   [Full Text] [Related]  

  • 27. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 28. Technology transfer and idea commercialization.
    Sheft J
    Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
    [No Abstract]   [Full Text] [Related]  

  • 29. Riding the risk cycle.
    Chandwani R; Portman S
    Nat Biotechnol; 2004 Sep; 22(9):1187. PubMed ID: 15384190
    [No Abstract]   [Full Text] [Related]  

  • 30. On the biotech block.
    Ossola A
    Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
    [No Abstract]   [Full Text] [Related]  

  • 31. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 32. Marriage guidance for collaborators.
    Hogan J
    Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The YIC factor.
    Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
    [No Abstract]   [Full Text] [Related]  

  • 34. Stranger in a strange land?
    Dahiyat B
    Nat Biotechnol; 2012 Nov; 30(11):1030-2. PubMed ID: 23138291
    [No Abstract]   [Full Text] [Related]  

  • 35. Integrating the intellectual property value chain.
    Barrett B; Crawford D
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE43-6. PubMed ID: 12089587
    [No Abstract]   [Full Text] [Related]  

  • 36. Partnering challenges for startups.
    French JM
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE40-2. PubMed ID: 12089586
    [No Abstract]   [Full Text] [Related]  

  • 37. Timing and the transitory nature of biotech startups.
    Bottles K
    Physician Exec; 2001; 27(4):55-7. PubMed ID: 11481895
    [No Abstract]   [Full Text] [Related]  

  • 38. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 39. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 40. Boldness, but with realism.
    Nat Biotechnol; 2004 Aug; 22(8):927. PubMed ID: 15286627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.